Clinical Trial Update: A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating OQL011 for hand-foot skin reaction in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Skin Reaction

Drugs mentioned

• OQL011

Snippet

Sponsor: OnQuality Pharmaceuticals (USA) LLC | Conditions: Hand-Foot Skin Reaction (HFSR) | Phase 2 | Status: UNKNOWN